Ross Thomas Salvaris (Ross T Salvaris, Ross Salvaris)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Monoclonal Antibody

Diffuse Large B Cell Lymphoma

Chronic Lymphocytic Leukemia

Clinical Practice

Top Venues

Internal medicine journal

Leukemia & lymphoma

Journal of personalized medicine

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Masa Lasica, Mary A Anderson, Alex Boussioutas, Gareth Peter Gregory, Nada Hamad, Kate Manos, Penny McKelvie, Michael Ng, Belinda Campbell, Emma Palfreyman, Ross Thomas Salvaris, Robert Weinkove, Joel Wight, Stephen Opat, Constantine S Tam
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance. Internal medicine journal 54 (6) (2024)
Masa Lasica, Mary A Anderson, Alex Boussioutas, Gareth Peter Gregory, Nada Hamad, Kate Manos, Penny McKelvie, Michael Ng, Belinda Campbell, Emma Palfreyman, Ross Thomas Salvaris, Robert Weinkove, Joel Wight, Stephen Opat, Constantine S Tam
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance. Internal medicine journal 54 (6) (2024)
Ross Thomas Salvaris, Benjamin Michael Allanson, Chan Yoon Y Cheah
Using next generation sequencing to guide treatment of co-existing T-cell lymphoma and chronic myelomonocytic leukemia. Leukemia & lymphoma (2023)
Ross Thomas Salvaris, Stephen P Mulligan, Andrea Puig, Marija McGeachie, Stephen Samuel Opat
Australian data on the utilisation and duration on treatment of ibrutinib with a proton pump inhibitor in patients with relapsed or refractory chronic lymphocytic leukaemia. Internal medicine journal (2023)
Ross Thomas Salvaris, Chan Yoon Y Cheah
Time to omit interim CT imaging during frontline chemoimmunotherapy for patients with follicular lymphoma? Leukemia & lymphoma (2022)
Ross Thomas Salvaris, Jeremy Ong, Gareth Peter Gregory
Bispecific Antibodies: A Review of Development, Clinical Efficacy and Toxicity in B-Cell Lymphomas. Journal of personalized medicine 11 (5) (2021)
Ross Thomas Salvaris, Pasquale Luke Fedele
Targeted Therapy in Acute Lymphoblastic Leukaemia. Journal of personalized medicine 11 (8) (2021)
Ross Thomas Salvaris, Stephen Samuel Opat
An update of venetoclax and obinutuzumab in chronic lymphocytic leukemia. Future oncology (London, England) 17 (4) (2020)